5 Future directions
5.1.8 Effect of blood components on outcomes
Question 8 (interventional)
In patients undergoing surgery, what is the effect of FFP, cryoprecipitate, fibrinogen concentrate, and/or platelet transfusion on patient outcomes?
FFP, fresh frozen plasma
There was no evidence to support the prophylactic use of FFP in patients undergoing cardiac surgery. Outside this context, the literature is insufficient to address the indications for, timing of and dose of blood component therapies. There remains a need for further studies to address these issues.